美常安联合六味安消治疗慢性功能性便秘的疗效观察

摘要

Objective To evaluate abstract the therapeutic effects of Medilac-S combined with Liuwei-Anxiao on chronic functional constipation. Methods 89 patients with chronic functional constipation were randomly divided into 3 groups: Medilac-S plus Liuwei-Anxiao group(A,n=31),Medilac-S group(B,n=30), Liuwei-Anxiao group(C,n=28),the treatment lasted for 4 weeks.Results After 4 weeks of treatment, the total remission rates were 96.77%, 53.33%, 57.14% respectively in group A, B and C, A group was significantly higher than that of B and C groups (P<0.05).Conclusion Combined use of Medilac-S with Liuwei-Anxiao on chronic functional constipation is better than one drug alone, and the results are obvious, safe,and effective, worthy of clinical application.%目的：评价美常安联合六味安消治疗慢性功能性便秘的疗效。方法慢性功能性便秘患者89例，采用平行、双盲、随机的方法分为三组，A 组（n=31）口服美常安+六味安消，B 组（n=30）口服美常安，C 组（n=28）口服六味安消，治疗疗程为4周。结果治疗4周后，三组总缓解率分别为96.77%，53.33%，57.14%，A 组显著高于 B 和 C 两组（P ＜0.05）。结论美常安联合六味安消治疗慢性功能性便秘优于单用一种药物，且效果明显，安全有效，值得临床推广应用。